ஐரோப்பிய ஹீமாட்டாலஜி சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BeiGene Receives Positive CHMP Opinion for BRUKINSA (Zanubrutinib) for the Treatment of Adults with Waldenström s Macroglobulinemia

BeiGene Receives Positive CHMP Opinion for BRUKINSA (Zanubrutinib) for the Treatment of Adults with Waldenström s Macroglobulinemia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited arab emiratesJane huangChristian buskeGabrielle zhouUniversity hospital ulmEuropean commissionEuropean hematology associationExchange commissionEuropean unionEuropean medicines agencyBristol myers squibbInternational workshop on waldenstrCommittee for medicinal products human useLymphoma research foundationMedicinal products

BeiGene Receives Positive CHMP Opinion for BRUKINSA® (Zanubrutinib) for the Treatment of Adults with Waldenström s Macroglobulinemia

BeiGene Receives Positive CHMP Opinion for BRUKINSA® (Zanubrutinib) for the Treatment of Adults with Waldenström s Macroglobulinemia
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesUnited arab emiratesJane huangChristian buskeUniversity hospital ulmEuropean commissionEuropean hematology associationBeigene co ltdExchange commissionEuropean unionEuropean medicines agencyBristol myers squibbInternational workshop on waldenstrCommittee for medicinal products human useLymphoma research foundationMedicinal products

Oncopeptides publishes report for Q2 2021

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat.

United statesMartyj duvallAnders martinRolf gulliksenKlaas bakkerLinda holmstrEuropean hematology associationGlobal head of corporate communicationsNasdaq stockholmClinical oncologyAnders martin lGlobal headCorporate communicationsInvestor relationsAbuse regulationSecurities markets

Forma Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update - Press Release

Forma Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update - Press Release
wiredprnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiredprnews.com Daily Mail and Mail on Sunday newspapers.

United statesJohne bishopFrank leeAmerican society of clinical oncologyEuropean hematology associationDrug administrationEpizyme incVirtual international conference on molecularExchange commissionDevelopment rd expensesForma therapeutics holdings incVirtual congressProgram in prostate cancerProgram in sickle cell diseaseInternational conferenceMolecular targets

Protagonist Therapeutics Reports Second Quarter 2021 Financial Results and Recent Company Progress

Protagonist Therapeutics Reports Second Quarter 2021 Financial Results and Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesDineshv patelJanssen biotech incPrnewswire protagonist therapeutics incEuropean hematology associationProtagonist therapeutics incExchange commissionDevelopment rd expensesDrug administration breakthrough therapy designationVirtual congressChief executiveDrug administrationBreakthrough therapySubcutaneous injectable hepcidin mimeticPolycythemia veraBreakthrough therapy designation